Abstract
Artificial intelligence will undoubtedly shape technological developments in the next years – affecting biobanks as well. First concepts already exist for the possible application of AI in biobank processes. Data quality, which depends on sample quality, plays the decisive role here. For this reason, high and also overarching quality standards are important to prepare biobanks for these technological innovations. In addition, the requirements for sample and data quality will be significantly affected by the EU regulation for in vitro diagnostics as its transition period ends in 2022. The demand for human biospecimens will consequently rise.
In order to meet such requirements, the German Biobank Node (GBN) and the German Biobank Alliance (GBA) have established a quality management programme for German biobanks which includes e.g. an extensive quality manual and so-called “friendly” (cross-biobank) audits. The following article describes these developments with regard to their relevance for future biobank workflows using AI methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
BBMRI-ERIC - Biobanking and BioMolecular Resources Research Infrastructure - European Research Infrastructure Consortium. www.bbmri-eric.eu
German Biobank Node (GBN): bbmri.de
Schmitt, S., et al.: German Biobank Node: Manual for Quality Management in Biobanking - English Version. https://doi.org/10.5281/zenodo.3697691
Herpel, E., Schmitt, S., Kiehntopf, M.: Quality of biomaterials in liquid- and tissue-biobanking. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 59(3), 325–335 (2015). https://doi.org/10.1007/s00103-015-2294-3
Cooperation between German Biobank Node, German Cancer Research Center in Heidelberg, Biobanking and Biomolecular Resources Research Infrastructure - European Research Infrastructure Consortium. https://samplelocator.bbmri.de/
Huppertz, B., Holzinger, A.: Biobanks – a source of large biological data sets: open problems and future challenges. In: Holzinger, A., Jurisica, I. (eds.) Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. LNCS, vol. 8401, pp. 317–330. Springer, Heidelberg (2014). https://doi.org/10.1007/978-3-662-43968-5_18
Müller, H., et al.: State-of-the-art and future challenges in the integration of biobank catalogues. In: Holzinger, A., Röcker, C., Ziefle, M. (eds.) Smart Health. LNCS, vol. 8700, pp. 261–273. Springer, Cham (2015). https://doi.org/10.1007/978-3-319-16226-3_11
Wilkinson, M.D.: The FAIR guiding principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016). https://doi.org/10.1038/sdata.2016.18
Courdray, N., et al.: Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat. Med. 24(10), 1559–1567 (2018). https://doi.org/10.1038/s41591-018-0177-5
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hartfeldt, C. et al. (2020). Sample Quality as Basic Prerequisite for Data Quality: A Quality Management System for Biobanks. In: Holzinger, A., Goebel, R., Mengel, M., Müller, H. (eds) Artificial Intelligence and Machine Learning for Digital Pathology. Lecture Notes in Computer Science(), vol 12090. Springer, Cham. https://doi.org/10.1007/978-3-030-50402-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-50402-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50401-4
Online ISBN: 978-3-030-50402-1
eBook Packages: Computer ScienceComputer Science (R0)